The events industry is a multi-million dollar industry, ergo it is a key target for corruption. 'The Dark Side of Events' identifies the ‘weak spots’ and opportunities, and advises how to identify and prevent corruption. It applies the advanced tools of risk management found in the ISO31010, 31000, 37001 to the prevention of corruption in events.

"What every leader needs to know about dignity and how to create a culture in which everyone thrives. This landmark book from an expert in dignity studies explores the essential but under-recognized role of dignity as part of good leadership. Extending the reach of her award-winning book Dignity: Its Essential Role in Resolving Conflict, Donna Hicks now contributes a specific, practical guide to achieving a culture of dignity. Most people know very little about dignity, the author has found, and when leaders fail to respect the dignity of others, conflict and distrust ensue. She highlights three components of leading with dignity: what one must know in order to honor dignity and avoid violating it; what one must do to lead with dignity; and how one can create a culture of dignity in any organization, whether corporate, religious, governmental, healthcare, or beyond. Brimming with key research findings, real-life case studies, and workable recommendations, this book fills an important gap in our understanding of how best to be together in a conflict-ridden world."--

The Dark Side is a dramatic, riveting, and definitive narrative account of how the United States made self-destructive decisions in the pursuit of terrorists around the world—decisions that not only violated the Constitution, but also hampered the pursuit of Al Qaeda. In spellbinding detail, Jane Mayer relates the impact of these decisions by which key players, namely Vice President Dick Cheney and his powerful, secretive adviser David Addington, exploited September 11 to further a long held agenda to enhance presidential powers to a degree never known in U.S. history, and obliterate Constitutional protections that define the very essence of the American experiment. With a new afterward. One of The New York Times 10 Best Books of the Year National Bestseller National Book Critics Circle Award Finalist A Best Book of the Year: Salon, Slate, The Economist, The Washington Post, Cleveland Plain-Dealer

The Dark Side of Technology is intended as a powerful wake-up call to the potential dangers that could, in the near future, destroy our current advanced civilizations. The author examines how fragile our dependence on electronic communications, information storage, and satellites is, as vulnerability increases in an age of raising security concerns. This weakness is evident from the exponential rise in cyber-crime and terrorism. Satellites are crucial to modern-day living, but they can be destroyed by energetic space debris or damaged by solar emissions. Destruction of data, communications, and electrical power grids would bring disaster to advanced nations. Such events could dramatically change our social and economic landscapes within the next 10-20 years. New technology equally impacts employment, agriculture, biology, medicine, transport, languages, and our social well-being. This book explores both the good and the bad aspects of technological advances, in order to raise awareness and promote caution. Technology may be impressive, but we need to be mindful of potential negative future effects. We ought to seriously consider the long term consequences of an increasing failure to pursue healthy life styles, use of ineffective antibiotics, genetic mutations, and the destruction of food supplies and natural resources. The diverse topics covered aims to show why we must act now to plan for both the predictable downsides of technology, and also develop contingency plans for potential major catastrophes, including natural events where we cannot define accurate time scales.

The many con men, gangsters, and drug lords portrayed in popular culture are examples of the dark side of the American dream. Viewers are fascinated by these twisted versions of heroic American archetypes, like the self-made man and the entrepreneur. Applying the critical skills he developed as a Shakespeare scholar, Paul A. Cantor finds new depth in familiar landmarks of popular culture. He invokes Shakespearean models to show that the concept of the tragic hero can help us understand why we are both repelled by and drawn to figures such as Vito and Michael Corleone or Walter White. Beginning with Huckleberry Finn and ending with The Walking Dead, Cantor also uncovers the link between the American dream and frontier life. In imaginative variants of a Wild West setting, popular culture has served up disturbing—and yet strangely compelling—images of what happens when people move beyond the borders of law and order. Cantor demonstrates that, at its best, popular culture raises thoughtful questions about the validity and viability of the American dream, thus deepening our understanding of America itself.

A ground-breaking comparative analysis of cinematic images of atrocity, combining critical perspectives on contemporary film and human rights.A few days after 9/11, US Vice-President Dick Cheney invoked the need for the USA to work 'the dark side' in its global 'War on Terror'. Cinema of the Dark Side explores how contemporary cinema treats state-sponsored atrocity, evoking multiple landscapes of state terror. Investigating the ethical potential of cinematic atrocity images, this book argues that while films help to create and confirm normative perceptions about atrocities, they can also disrupt those perceptions and build alternative ones. Asserting a crucial distinction between morality and ethics, it proposes a new conceptualisation of human rights cinema, one that repositions human rights morality within an ethical framework that reflects upon the causes and contexts of violence. It builds upon theories of embodied perception to offer a new perspective on the ethics of spectatorship, providing readers with fresh insights into how we respond to atrocity images and the ethical issues at stake.Covering a diverse spectrum of 21st century cinema, this book deals with documentary and fictional representations of atrocity such as state-sanctioned torture, genocide, enforced disappearance, deportation, and apartheid. It features close analysis of contemporary films, including Zero Dark Thirty, Standard Operating Procedure, Hotel Rwanda, Sometimes in April, Nostalgia for the Light, Chronicle of an Escape, Children of Men, District 9, Waltz With Bashir, and Paradise Now.

In the early decades since the introduction in the early '80s of immunoglobulin therapy many studies tried to identify which clinical indications might benefit from the therapy, which treatment’s schedules are effective and safe. It is universally accepted that immunoglobulin therapy is a life-saving treatment in patients with PID. The rise of new indications for further different clinical conditions resulted in a steady increase in demand for immunoglobulins. Currently the consumption of immunoglobulin for PID represents a small fraction of the market. In the recent past we have been observing: 1) An increase in the demand for plasma and in the consequent need to increase the number of donors; 2) Changes in methods to improve IgG recovery and to increase productivity as a response to growing clinical demand; 3) Introduction of immunoglobulin treatments with higher concentration; 4) Changes in the timing of administration with an increase in the rate of infusion; 5) Introduction of immunoglobulin treatment administered subcutaneously mainly confined initially to patients with PID and later extended to other clinical indications which often require higher volumes of infusion. Doctors following patients with PID were initially alarmed only to a possible risk of shortage. More relevant and less discussed appear the possible consequences of: 1) the risk of an improper transfer of information on treatments from a clinical indication to another. In particular, the idea of a mere replacement function in patients with PID might possibly be borrowed from the model of other clinical conditions requiring a replacement such as haemophilia. In PID, immunoglobulin treatment instead is obviously replacing a missing feature. However, other immune alterations are responsible for the large number of PID-associated diseases including inflammatory manifestations and tumors, common causes of morbidity and mortality. The immunomodulatory effects of immunoglobulin administered at replacement dosages on multiple cells and immune system functions are still largely to be checked in in vitro studies and in vivo. 2) the changes in the immunoglobulin production and schedules of administration. These should have been assessed in studies of drug surveillance, necessary in order to evaluate on large numbers of what it is initially reported on patients enrolled in the pivotal clinical trials, usually in the absence of most of the main disease-associated clinical conditions affecting pharmacokinetics, efficacy and tolerability. Severe side effects are now more frequently reported. This requires surveillance studies in order to verify the tolerability. Nowadays, personalized health research presents methodologic challenges, since emphasis is placed on the individual response rather than on the population. Even within a universally accepted indication, such as in PID, the identification of prognostic markers should guide the therapeutic intervention. 3) the risk of a decrease in the surveillance and monitoring of PID-associated clinical conditions. In fact, self- administration of immunoglobulins administered subcutaneously increased the independence of a number of patients. On the other hand, it led to the reduction in the number of contacts between specialized centers and patients who often require a close monitoring of disease-associated conditions. A wide debate between experts is necessary to afford the new challenge on immunoglobulin usage.